Reported Nov 11, 2020 · Ongoing
Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count bottles, Rx Only. Manufactured by: Nostrum…
Nostrum Laboratories Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Nostrum Laboratories Inc · 1800 N Topping Ave · Kansas City, MO · 64120-1228
Is this the product you have?
- Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count bottles, Rx Only
- Manufactured byNostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-056-01
- Lot codes and dates
MET200101MET200301 EXP 05/2022
- Amount recalled
- 12,967 bottles
This recall covers 2 products
The agency filed one notice per product. You are reading one of them; the other one is below.
Where it was sold
- Nationwide
Why it was recalled
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Nostrum Laboratories Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.